Stay updated with breaking news from Retinal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Opus to advance preclinical development programs for BEST1- and RHO-related retinal diseases Opus Genetics, a patient-first, clinical-stage gene therapy company
Diabetic retinopathy (DR), a primary cause of blindness in working-age people, affects about one-third of diabetic patients
Vabysmo achieved its primary endpoint of non-inferiority to aflibercept in RVO in the BALATON and COMINO clinical trials Vabysmo was generally well tolerated, with a safety profile consistent with previous
SOUTH SAN FRANCISCO (dpa-AFX) - Genentech, a member of Swiss drug major Roche Group (RHHBY), announced Thursday positive topline results from Phase III trials that showed Vabysmo improved vision
Egypt: Ocular alterations are more likely to occur in those with non-segmental vitiligo states a study published in the Australasian Journal of Dermatology.About 1% of people worldwide suffer from...